Vascular Solutions Inc. (VASC) is Conestoga Capital Advisors LLC’s 6th Largest Position
Conestoga Capital Advisors LLC reduced its position in Vascular Solutions Inc. (NASDAQ:VASC) by 14.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 912,176 shares of the medical device company’s stock after selling 147,935 shares during the period. Vascular Solutions makes up about 3.0% of Conestoga Capital Advisors LLC’s portfolio, making the stock its 6th largest position. Conestoga Capital Advisors LLC owned approximately 5.22% of Vascular Solutions worth $43,994,000 at the end of the most recent quarter.
Several other large investors have also recently made changes to their positions in the company. First Mercantile Trust Co. increased its stake in shares of Vascular Solutions by 129.4% in the third quarter. First Mercantile Trust Co. now owns 4,242 shares of the medical device company’s stock worth $205,000 after buying an additional 2,393 shares during the last quarter. Eqis Capital Management Inc. increased its stake in shares of Vascular Solutions by 16.7% in the third quarter. Eqis Capital Management Inc. now owns 8,197 shares of the medical device company’s stock worth $395,000 after buying an additional 1,171 shares during the last quarter. Mason Street Advisors LLC purchased a new stake in shares of Vascular Solutions during the second quarter worth about $141,000. Schwab Charles Investment Management Inc. increased its stake in shares of Vascular Solutions by 2.0% in the second quarter. Schwab Charles Investment Management Inc. now owns 59,446 shares of the medical device company’s stock worth $2,477,000 after buying an additional 1,194 shares during the last quarter. Finally, Stifel Financial Corp increased its stake in shares of Vascular Solutions by 4.9% in the second quarter. Stifel Financial Corp now owns 170,869 shares of the medical device company’s stock worth $7,119,000 after buying an additional 7,987 shares during the last quarter. 84.55% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Vascular Solutions Inc. (NASDAQ:VASC) remained flat at $53.85 on Monday. 66,936 shares of the company were exchanged. The stock has a 50 day moving average price of $47.59 and a 200 day moving average price of $44.63. The firm has a market capitalization of $944.15 million, a price-to-earnings ratio of 78.27 and a beta of 0.87. Vascular Solutions Inc. has a one year low of $24.34 and a one year high of $54.00.
Vascular Solutions (NASDAQ:VASC) last released its quarterly earnings results on Monday, October 24th. The medical device company reported $0.31 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.30 by $0.01. The business earned $41.80 million during the quarter. Vascular Solutions had a return on equity of 16.14% and a net margin of 7.57%. The company’s revenue for the quarter was up 13.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.27 earnings per share. On average, equities analysts expect that Vascular Solutions Inc. will post $1.24 earnings per share for the current fiscal year.
A number of brokerages have recently issued reports on VASC. Zacks Investment Research raised shares of Vascular Solutions from a “hold” rating to a “buy” rating and set a $52.00 price target on the stock in a report on Thursday, October 27th. Needham & Company LLC reaffirmed a “buy” rating and issued a $58.00 target price on shares of Vascular Solutions in a research note on Wednesday, October 26th. Canaccord Genuity set a $53.00 target price on shares of Vascular Solutions and gave the company a “buy” rating in a research note on Tuesday, October 25th. TheStreet raised shares of Vascular Solutions from a “hold” rating to a “buy” rating in a research note on Monday, July 25th. Finally, Piper Jaffray Cos. raised their target price on shares of Vascular Solutions from $45.00 to $49.00 and gave the company an “overweight” rating in a research note on Tuesday, July 26th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $51.80.
Vascular Solutions Company Profile
Vascular Solutions, Inc is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world.
Receive News & Stock Ratings for Vascular Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vascular Solutions Inc. and related stocks with our FREE daily email newsletter.